{
  "docId": "019de06f-57cf-712e-a58f-75e608a89acf",
  "docSlug": "72cbc476cbb3df5012eb344c4961ce5a",
  "documentTitle": "Bausch Health Companies | Mergers and Acquisitions Presentation Deck | 40 slides",
  "authorId": "bausch-health-companies",
  "authorName": "Valeant",
  "documentKindSlug": "consulting-deck",
  "documentKindLabel": "Consulting deck",
  "sourceTypeSlug": "investment_bank",
  "sourceTypeLabel": "Investment bank",
  "presentationDate": "2014-09-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.5571777,
  "pageNumber": 15,
  "pageCount": 40,
  "prevPage": 14,
  "nextPage": 16,
  "slideType": "case_study",
  "function": "illustrate_case",
  "density": "balanced",
  "nDataPoints": 4,
  "notes": "The slide contrasts the $35M development cost of Jublia against the industry average of $1.2B.",
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de06f-57cf-712e-a58f-75e608a89acf/15",
  "deckHref": "/decks/019de06f-57cf-712e-a58f-75e608a89acf",
  "deckJsonHref": "/decks/019de06f-57cf-712e-a58f-75e608a89acf.json",
  "deckAnchorHref": "/decks/019de06f-57cf-712e-a58f-75e608a89acf#slide-15",
  "components": [
    {
      "bbox": {
        "h": 0.2,
        "w": 0.2,
        "x": 0.76,
        "y": 0.38
      },
      "kind": "callout",
      "text": "Expected peak sales of $300-800M in 2018",
      "attrs": null,
      "subkind": "primary",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "a7d7df3b-4acc-496a-90c4-45d7fb0c0c79",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.1,
        "w": 0.2,
        "x": 0.75,
        "y": 0.02
      },
      "kind": "image",
      "text": "JUBLIA (efinaconazole) Topical Solution 10%",
      "attrs": null,
      "subkind": "logo",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "d038854a-cadd-46a6-b81a-5f7de65b0302",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.6,
        "w": 0.7,
        "x": 0.05,
        "y": 0.2
      },
      "kind": "list",
      "text": "Approved June 8th, 2014\nTotal development costs of ~$35M from NCE to approval\nSubstantially lower cost than typical estimates of drug development of approximately $1.2B per NCE\nUtilized distinctive development expertise where it matters\nInternal team focused on critical activities\nLeveraged DOW team for formulation expertise\nAll other activities via vendors / CROs\nMade technical leads responsible for all functions related to their area – 'entrepreneurial/start-up' model\nFull time project team of 7 FTEs",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "f7d1beb5-a9de-4820-a127-f91bbacf39a5",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.1,
        "w": 0.4,
        "x": 0.6,
        "y": 0.85
      },
      "kind": "source-note",
      "text": "1 Total cost since 2006 (Valeant acquired in 2008)\n2 $1.2B as per PhRMA profile 2013",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "b919cfbd-bdc7-40b6-9054-a9f6e67425fc",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.1,
        "w": 0.6,
        "x": 0.05,
        "y": 0.05
      },
      "kind": "title",
      "text": "Case Example: Internal R&D Jublia North America",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "e57b6f02-c4a9-4769-a126-2e2df3a765bc",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [],
  "arcBeats": [
    {
      "to": 24,
      "from": 11,
      "beatId": "db5c924d-e00d-4a10-88fb-f95fe8125dc5",
      "arcName": "The Consultant's Gambit",
      "arcSlug": "consultants-gambit",
      "beatName": "Problem & Complication",
      "beatSlug": "consultants-gambit-problem-complication",
      "evidence": "Industry trends, market landscape, and challenges in aesthetics",
      "position": 1,
      "confidence": 0.8,
      "parentBeatName": "Complication",
      "parentBeatSlug": "complication"
    }
  ],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}